Performance of Transient Elastography for the Staging of Liver Fibrosis in Patients with Chronic Hepatitis B: A Meta-Analysis

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Chon, Young Eun ^a   Choi, Eun Hee ^a   Song, Ki Jun ^a   Park, Jun Yong ^a,b   Kim, Do Young ^a,b   Han, Kwang Hyub ^a,b   Chon, Chae Yoon ^a,b   Ahn, Sang Hoon ^a,b   Kim, Seung Up ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Liver Cirrhosis Clinical Research Centre   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ELASTOGRAPHY; FEMALE; HEPATITIS B; HUMAN; INTERMETHOD COMPARISON; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TRANSIENT ELASTOGRAPHY;

AREA UNDER CURVE; ELASTICITY IMAGING TECHNIQUES; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; ROC CURVE; SEVERITY OF ILLNESS INDEX;

HEPATITIS C VIRUS;

EID: 84866658173     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044930     Document Type: Article

References (56)

1. Kim SU, Han K, Ahn SH, (2010) Non-invasive assessment of liver fibrosis: time to move from cross-sectional studies to longitudinal ones. Journal of Gastroenterology and Hepatology 25: 1472-1473.
2. Pungpapong S, Kim WR, Poterucha J, (2007) Natural history of hepatitis B virus infection: an update for clinicians. Mayo Clinic Proceedings Mayo Clinic 82: 967-975.
3. Yoshida H, Shiratori Y, Moriyama M, Arakawa Y, Ide T, et al. (1999) Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy. Annals of Internal Medicine 131: 174-181.
4. Bravo AA, Sheth SG, Chopra S, (2001) Liver biopsy. New England Journal of Medicine 344: 495-500.
5. Rousselet M, Michalak S, Dupr F, Crou A, Bedossa P, et al. (2005) Sources of variability in histological scoring of chronic viral hepatitis. Hepatology (Baltimore, Md) 41: 257-264.
6. Bedossa P, Dargre D, Paradis V, (2003) Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology (Baltimore, Md). 38: 1449-1457.
7. Wai C, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, et al. (2003) A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology (Baltimore, Md). 38: 518-526.
8. Kim BK, Kim SA, Park YN, Cheong JY, Kim HS, et al. (2007) Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B. Liver International. 27: 969-976.
9. Sheth SG, Flamm SL, Gordon FD, Chopra S, (1998) AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. The American Journal of Gastroenterology 93: 44-48.
10. Ganne-Carri N, Ziol M, de Ledinghen V, Douvin C, Marcellin P, et al. (2006) Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology (Baltimore, Md) 44: 1511-1517.
11. Foucher J, Chanteloup E, Vergniol J, Castra L, Le Bail B, et al. (2006) Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 55: 403-408.
12. Castra L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, et al. (2005) Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 128: 343-350.
13. Nahon P, Thabut G, Ziol M, Htar MT, Cesaro F, et al. (2006) Liver stiffness measurement versus clinicians' prediction or both for the assessment of liver fibrosis in patients with chronic hepatitis C. The American Journal of Gastroenterology. 101: 2744-2751.
14. Kettaneh A, Marcellin P, Douvin C, Poupon R, Ziol M, et al. (2007) Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. Journal of Hepatology 46: 628-634.
15. Talwalkar JA, Kurtz DM, Schoenleber SJ, West CP, Montori VM, (2007) Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clinical Gastroenterology and Hepatology 5: 1214-1220.
16. Stebbing J, Farouk L, Panos G, Anderson M, Jiao LR, et al. (2010) A meta-analysis of transient elastography for the detection of hepatic fibrosis. Journal of Clinical Gastroenterology 44: 214-219.
17. Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, et al. (2008) Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 134: 960-974.
18. Tsochatzis EA, Gurusamy KS, Ntaoula S, Cholongitas E, Davidson BR, et al. (2011) Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. Journal of Hepatology 54: 650-659.
19. Kim DY, Kim SU, Ahn SH, Park JY, Lee JM, et al. (2009) Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B. Digestive Diseases and Sciences. 54: 1758-1763.
20. Kim SU, Seo YS, Cheong JY, Kim MY, Kim JK, et al. (2010) Factors that affect the diagnostic accuracy of liver fibrosis measurement by Fibroscan in patients with chronic hepatitis B. Alimentary Pharmacology & Therapeutics. 32: 498-505.
21. Sandrin L, Fourquet B, Hasquenoph J, Yon S, Fournier C, et al. (2003) Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound in Medicine & Biology 29: 1705-1713.
22. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Controlled Clinical Trials 7: 177-188.
23. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J, (2003) The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Medical Research Methodology 3: 25.
24. Chan HL, Wong GL, Choi PC, Chim AM, Yiu KK, et al. (2009) Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. Journal of Viral Hepatitis. 16: 36-44.
25. Marcellin P, Ziol M, Bedossa P, Douvin C, Poupon R, et al. (2009) Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver International. 29: 242-247.
26. Wong GL, Wong VW, Choi PC, Chan AW, Chum RH, et al. (2008) Assessment of fibrosis by transient elastography compared with liver biopsy and morphometry in chronic liver diseases. Clinical Gastroenterology and Hepatology 6: 1027-1035.
27. Kim SU, Kim do Y, Park JY, Lee JH, Ahn SH, et al. (2010) How can we enhance the performance of liver stiffness measurement using FibroScan in diagnosing liver cirrhosis in patients with chronic hepatitis B? Journal of Clinical Gastroenterology 44: 66-71.
28. Wang JH, Changchien CS, Hung CH, Eng HL, Tung WC, et al. (2009) FibroScan and ultrasonography in the prediction of hepatic fibrosis in patients with chronic viral hepatitis. Journal of Gastroenterology 44: 439-446.
29. Kim SU, Ahn SH, Park JY, Kang W, Kim do Y, et al. (2009) Liver stiffness measurement in combination with noninvasive markers for the improved diagnosis of B-viral liver cirrhosis. Journal of Clinical Gastroenterology 43: 267-271.
30. Sporea I, Sirli R, Deleanu A, Tudora A, Popescu A, et al. (2010) Liver stiffness measurements in patients with HBV vs HCV chronic hepatitis: a comparative study. World Journal of Gastroenterology: WJG 16: 4832-4837.
31. Jeon SW, Cho CM, Park YD, Jung YJ, Tak WY, et al. (2006) Correlation between liver elasticity measured by FibroScan® and liver fibrosis assessed by histology; Preliminary study in Korea. Digestive Disease Week S1610.
32. Chang J, Tan HH, Yew BS, Thia K, Ang D, et al. (2006) Transient elastography(FibroScan®) to assess hepatic fibrosis in Chinese with chronic hepatitis B. Hepatology International. 1: 785.
33. Tanwandee T, Charatcharoenwitthaya P, Viboolsirikul V, Chotiyaputta W, Chainuvati S, et al. (2008) Utility of liver stiffness measured by transient elastography for determining significant liver fibrosis in patients with chronic hepatitis B. Hepatology (Baltimore, Md). 48: 709.
34. Choi JW, Kim DY, Park JY, Ahn SH, Yoon KT, et al. (2008) Clinical usefulness of liver stiffness measurement in HBeAg-positive chronic hepatitis B patients with ALT level <2 times upper limit of normal. Hepatology (Baltimore, Md) 48: 750.
35. Castera L, Bernard PH, LeBail LB, Foucher J, Trimoulet P, et al. (2009) Prospective longitudinal comparison of trenasient elastography (fibroscan) and fibrotest for discriminating inactive hepatitis B carriers from HBeAg-negative disease. Hepatology (Baltimore, Md) 50: 978.
36. Chang J, Lui HF, Tan CK, Chow WC, (2009) Transient elastography (FibroScan®) is reliable for non-invasive diagnosis of significant fibrosis in chronic hepatitis B with milde transaminitis but becomes less reliable at higher ALT levels. Hepatology (Baltimore, Md) 50: 501.
37. Jia JD, Hou JL, Ding HG, Chen JM, Xie Q, et al. (2010) Liver stiffness measured by transient elastography can predict liver fibrosis in Chinese patients with chronic hepatitis B. Hepatology International. 4: 22.
38. Lesmana CR, Lesmana LA, Krisnuhoni E, Pakasi L, Salim S, et al. (2010) Diagnostic accuracy of transient elastography versus aspartate transaminase to platelet ratio index in assessing liver fibrosis in chronic hepatitis B: preliminary data. Hepatology International 4: 21.
39. Chen Y, Liang X, Dai L, Zhang Q, Hou J, (2011) Improving Performance of Liver Stiffness Measurement Detecting Liver Cirrhosis in Chinese Patient with Compensated Chronic Hepatitis B. Hepatology International. 54: 304.
40. Zhu X, Wang LC, Chen EQ, Chen LY, Tang H, (2011) Prospective Evaluation of FibroScan for the Diagnosis of Hepatic Fibrosis in Patients with Chronic Hepatitis B Virus Infection. Hepatology International 54: 306.
41. Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, et al. (2005) Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology (Baltimore, Md). 41: 48-54.
42. Verveer C, Zondervan PE, Ten Kate FJ, Hansen BE, Janssen HL, et al. (2011) Evaluation of transient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and C. Liver International.
43. Swets JA, (1988) Measuring the accuracy of diagnostic systems. Science 240: 1285-1293.
44. Chien R, Lin C, Liaw Y, (2003) The effect of lamivudine therapy in hepatic decompensation during acute exacerbation of chronic hepatitis B. Journal of Hepatology. 38: 322-327.
45. Garg H, Sarin SK, Kumar M, Garg V, Sharma BC, et al. (2011) Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure. Hepatology (Baltimore, Md) 53: 774-780.
46. Sturm N, Cheveau A, Arvers P (2009) Comparative morphometric assessment of fibrosis in chronic hepatitis B versus chronic hepatitis C liver biopsies: implication for fibrosis assessement by non invasive methods. Journal of Hepatology 50.
47. Gaia S, Carenzi S, Barilli AL, Bugianesi E, Smedile A, et al. (2011) Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. Journal of Hepatology 54: 64-71.
48. Fung J, Lai C, Cheng C, Wu R, Wong DK, et al. (2011) Mild-to-moderate elevation of alanine aminotransferase increases liver stiffness measurement by transient elastography in patients with chronic hepatitis B. The American Journal of Gastroenterology. 106: 492-496.
49. Kim SU, Han K, Ahn SH, (2011) Non-invasive assessment of liver fibrosis: the gap between ideal and real. Journal of Gastroenterology and Hepatology 26: 937-939.
50. Jung KS, Kim SU, Ahn SH, Park YN, Kim DY, et al. (2011) Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). Hepatology (Baltimore, Md) 53: 885-894.
51. Lok AS, McMahon BJ, (2009) Chronic hepatitis B: update 2009. Hepatology (Baltimore, Md) 50: 661-662.
52. Ghany MG, Strader DB, Thomas DL, Seeff LB, (2009) Diagnosis, management, and treatment of hepatitis C: an update. Hepatology (Baltimore, Md) 49: 1335-1374.
53. Foucher J, Vergniol J, Castera L, (2005) Fibrosis evaluation in chronic liver diseases: comparison of FibroScan® with liver biopsy, FibroTest®, Forns score, APRI, hyaluronan, prothrombin time, and AST/ALT ratio. Journal of Hepatology 42: 78A.
54. Masuzaki R, Tateishi R, Yoshida H, Goto E, Sato T, et al. (2009) Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography.
55. Kim SU, Kim JK, Park YN, Han K, (2012) Discordance between Liver Biopsy and FibroScan® in Assessing Liver Fibrosis in Chronic Hepatitis B: Risk Factors and Influence of Necroinflammation. PLoS One 7: e32233-e32233.
56. Chon YE, Jung ES, Park JY, Kim DY, Ahn SH, et al. (2012) The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B Journal of Clinical Gastroenterology. In press.